11.   If Herceptin is approved, it will be the first genetically engineered drug for the treatment of advanced breast cancer.

12.   In some clinics, women with advanced breast or ovarian cancer are being given smaller, more frequent doses of chemotherapy to reduce side effects.

13.   In studies, the drug has shown impressive results against advanced breast cancer when combined with standard chemotherapy drugs like Taxol.

14.   Internists, for example, say they have been penalized for discussing bone-marrow transplants as a possible treatment for women with advanced breast cancer.

15.   It was first used to treat advanced breast cancer, then to prevent recurrence of less advanced disease.

16.   Last December, the Oncologic Drugs Advisory Committee rejected Taxotere for both advanced breast cancer and non-small cell lung cancer because of its serious and sometimes fatal side effects.

17.   Last December, the Oncologic Drugs Advisory Committee rejected Taxotere for both advanced breast cancer and non-small cell lung cancer because of serious and sometimes fatal side effects.

18.   One of the most common and devastating complications of advanced breast cancer is when the disease spreads to bone.

19.   One such gene-based designer drug, Herceptin, is already marketed for treating advanced breast cancer.

20.   Panzem has been in testing at the University of Indiana Medical Center for treatment of advanced breast cancer, and at the Mayo Clinic in Minnesota for multiple myeloma.